Lyra Therapeutics Inc
NASDAQ:LYRA
Income Statement
Earnings Waterfall
Lyra Therapeutics Inc
Revenue
|
1.6m
USD
|
Operating Expenses
|
-67.1m
USD
|
Operating Income
|
-65.5m
USD
|
Other Expenses
|
2.8m
USD
|
Net Income
|
-62.7m
USD
|
Income Statement
Lyra Therapeutics Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+2 800%
|
1
+159%
|
1
+71%
|
2
+27%
|
1
-17%
|
1
-4%
|
1
-5%
|
1
+15%
|
2
+10%
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(17)
|
(17)
|
(17)
|
(20)
|
(22)
|
(26)
|
(32)
|
(37)
|
(44)
|
(48)
|
(52)
|
(56)
|
(56)
|
(63)
|
(62)
|
(64)
|
(67)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(8)
|
(10)
|
(11)
|
(13)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(19)
|
|
Research & Development |
(12)
|
(12)
|
(11)
|
(12)
|
(13)
|
(14)
|
(20)
|
(23)
|
(30)
|
(33)
|
(37)
|
(40)
|
(39)
|
(43)
|
(43)
|
(45)
|
(48)
|
|
Operating Income |
(17)
N/A
|
(17)
-4%
|
(17)
-2%
|
(20)
-12%
|
(22)
-14%
|
(26)
-16%
|
(32)
-25%
|
(37)
-15%
|
(44)
-18%
|
(48)
-9%
|
(51)
-7%
|
(55)
-7%
|
(55)
0%
|
(62)
-12%
|
(61)
+1%
|
(63)
-3%
|
(66)
-4%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(3)
|
(3)
|
(2)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(16)
N/A
|
(17)
-4%
|
(17)
-2%
|
(19)
-13%
|
(22)
-14%
|
(26)
-16%
|
(32)
-25%
|
(37)
-15%
|
(44)
-18%
|
(48)
-9%
|
(51)
-7%
|
(55)
-7%
|
(55)
-1%
|
(60)
-8%
|
(61)
-2%
|
(62)
-1%
|
(63)
-1%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(16)
|
(17)
|
(17)
|
(19)
|
(22)
|
(26)
|
(32)
|
(37)
|
(44)
|
(48)
|
(51)
|
(55)
|
(55)
|
(60)
|
(61)
|
(62)
|
(63)
|
|
Net Income (Common) |
(16)
N/A
|
(17)
-4%
|
(17)
-2%
|
(19)
-12%
|
(22)
-15%
|
(26)
-16%
|
(32)
-25%
|
(37)
-15%
|
(44)
-18%
|
(48)
-9%
|
(51)
-7%
|
(55)
-7%
|
(55)
-1%
|
(60)
-8%
|
(61)
-2%
|
(62)
-1%
|
(63)
-1%
|
|
EPS (Diluted) |
-1.32
N/A
|
-1.37
-4%
|
-1.39
-1%
|
-1.49
-7%
|
-2.59
-74%
|
-2
+23%
|
-2.48
-24%
|
-2.84
-15%
|
-3.35
-18%
|
-3.67
-10%
|
-0.97
+74%
|
-1.48
-53%
|
-1.83
-24%
|
-1.61
+12%
|
-1.39
+14%
|
-1.08
+22%
|
-1.26
-17%
|